|
TOMM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22568621918617E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.08304509594382E-12 |
| Normal-vs-Stage2 |
1.594970E-04 |
| Normal-vs-Stage3 |
2.25164331624228E-12 |
| Normal-vs-Stage4 |
1.62536650805123E-12 |
| Stage1-vs-Stage2 |
4.581000E-01 |
| Stage1-vs-Stage3 |
9.677500E-02 |
| Stage1-vs-Stage4 |
1.718560E-03 |
| Stage2-vs-Stage3 |
9.764400E-02 |
| Stage2-vs-Stage4 |
1.844460E-02 |
| Stage3-vs-Stage4 |
2.423200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58761892521397E-14 |
| Normal-vs-AfricanAmerican |
2.32479999695556E-08 |
| Normal-vs-Asian |
9.41490000405665E-08 |
| Caucasian-vs-AfricanAmerican |
4.250000E-01 |
| Caucasian-vs-Asian |
1.883830E-01 |
| AfricanAmerican-vs-Asian |
9.839500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.38458166943201E-14 |
| Normal-vs-Female |
1.82132087189757E-12 |
| Male-vs-Female |
6.782100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.87423426673195E-12 |
| Normal-vs-Age(41-60Yrs) |
1.78201897682584E-12 |
| Normal-vs-Age(61-80Yrs) |
9.04679997582036E-09 |
| Normal-vs-Age(81-100Yrs) |
2.33239999999357E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.272200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.855800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.635400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.235400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.708600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.503200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.693600E-01 |
| Classical-VS-Follicular |
3.51640000000319E-05 |
| Classical-VS-Other |
4.006800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
6.42349999999681E-05 |
| Tall-VS-Other |
1.983440E-01 |
| Tall-VS-Normal |
3.28359561763136E-11 |
| Follicular-VS-Other |
4.075800E-01 |
| Follicular-VS-Normal |
1.759760E-02 |
| Other-VS-Normal |
4.876600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.87020002104543E-09 |
| Normal-vs-N1 |
1.13542508728415E-12 |
| N0-vs-N1 |
4.243700E-03 |
|
|
